Research and Development

Showing 15 posts of 9612 posts found.

gsk_l_rgb

Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits

June 22, 2016 Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial

UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …
clinical_trial_3

Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug

June 22, 2016 Research and Development FDA, drug, huntington's disease, wave life sciences

Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …
entrance_takeda_i020_v1

Takeda begins world’s first norovirus vaccine field trial

June 22, 2016 Research and Development Takeda, Vaccine, norovirus

Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …
stocks2

Immunomedics’ chief financial officer resigns, shares fall

June 22, 2016 Research and Development, Sales and Marketing Immunomedics, Shares, cfo, stock market

Shares in Immunomedics (Nasdaq: IMMU) fell as much as 11% after the company said its chief financial officer Peter Pfreundschuh …

Nice backs two cancer drugs from Novartis

June 22, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, Humira, NICE, Novartis, Sanofi, lung cancer, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed two drugs form Novartis (VTX: NOVN) for lung cancer …
teva_copy

Impax to acquire Teva, Allergan generic drugs for $586 million

June 22, 2016 Research and Development, Sales and Marketing Allergan, Impax, Teva, generics

Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …

Murdo Gordon gets Chief Commercial Officer role at Bristol-Myers Squibb

June 21, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, chief commercial officer

Bristol-Myers Squibb (NYSE: BMY) has announced the appointment of Munro Gordon as executive vice president and chief commercial officer, effective …
amgen_flag

Amgen’s denosumab may help check breast cancer in women with BRCA1 gene – Study

June 21, 2016 Manufacturing and Production, Research and Development Amgen, Prolia, Xgeva, biotech, breast cancer, drug trial, genetics

US biotech firm Amgen’s (Nasdaq: AMGN) Prolia (denosumab) to treat osteoporosis and Xgeva to prevent fractures in cancer patients, may …
rd_hands

Auris Medical initiates Phase III trial for sudden deafness treatment

June 21, 2016 Manufacturing and Production, Research and Development auris medical, sudden deafness

Auris Medical (NASDAQ: EARS) has announced that it has initiated enrolment for a new Phase III trial that will evaluate …
novartis_side_building

Novartis aims to launch five major global biosimilars by 2020

June 21, 2016 Manufacturing and Production, Research and Development 2020, Novartis, Sandoz, biosimilars

Novartis (VTX: NOVN) has announced plans to triple its biosimilar portfolio by 2020, with the launch of five major biosimilar …
shutterstock_67313209

Doctors prescribe more brand drugs for free meals from pharma industry – Study

June 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing JAMA, regulation, research

Doctors who received free meals from the pharmaceutical representatives were more likely to prescribe the brand-name medication that was being …
aedes_aegypti_mosquito

First-in-man Zika vaccine trials get green light

June 21, 2016 Manufacturing and Production, Research and Development trials, zika vaccine

Inovio Pharmaceuticals (NASDAQ: INO) and GeneOne Life Science (KSE: 011000) have announced that approval has been granted for the commencement …
esteban

Amgen appoints Esteban Santos as executive VP of operations

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amgen (NASDAQ: AMGN) has announced the appointment of Esteban Santos as executive vice president, operations. Santos will be responsible for …
stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
nhs_sign

NHS looking to offer free healthcare apps, devices from next year

June 20, 2016 Medical Communications, Research and Development, Sales and Marketing DigitalHealth, HealthTech, NHS, NICE

The NHS will offer devices and apps for free to help patients manage their health, starting in UK next year.
The Gateway to Local Adoption Series

Latest content